2020 press releases
- TheraPanacea, Gustave Roussy, AP-HP, ICANS | Institut de cancérologie Strasbourg Europe and GE Healthcare target to improve brain tumor survival through AI-based personalized radiation treatment
Press release, 7 december 2020 - Pediatric Cancer Researchers Receive $1.3 Million to Study Precise Treatment for Neuroblastoma
Press release, 16 november 2020 - World's Best Specialized Hospitals 2021 - Newsweek magazine places Gustave Roussy among the top 5 best cancer hospitals in the world
Press release, 6 october 2020 - Daiichi Sankyo and Gustave Roussy Enter Innovative Research Collaboration for DXd ADCs DS-1062 and Patritumab Deruxtecan
Press release, 22 july 2020 - A new immunotherapeutic agent for children and adolescents with advanced lymphoma
Press release, 4 june 2020 - ASCO 2020 - The CAPRI program proves its clinical and economic efficiency for personalized remote monitoring of patients treated with oral anticancer drugs
Press release, 29 may 2020 - ASCO 2020 - Lung cancers: hopes for conjugated antibodies
Press release, 29 may 2020 - ASCO 2020 - Childhood cancers: Early promising results of a dual therapy in treatment of some low grade gliomas
Press release, 29 may 2020 - ASCO 2020 - Soft tissue sarcomas: combined therapy with doxorubicin-trabectedin shown to have a role as first-line treatment of leiomyosarcomas
Press release, 29 may 2020 - ASCO 2020 - Breast cancers: certain genetic abnormalities might predict efficacy of ribociclib
Press release, 29 may 2020 - Pr Antoine Italiano (institut Bergonié) joins Gustave Roussy to head the precision oncology program
Press release, 25 february 2020 - Professor Fabrice André appointed as Research Director at Gustave Roussy
Press release, 11 february 2020 - Artificial Intelligence in Oncology Strategic Alliance Between Owkin and Gustave Roussy Formed to Accelerate Clinical Research
Press release, 17 january 2020 - Professor Fabrice Barlesi becomes Gustave Roussy Medical Director
Press release, 13 january 2020
Catégorie de la page:
